Ilex Medical Ltd (TLV: ILX)

Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	150.35	148.38	200.96	259.23	159.83	50.42
Short-Term Investments	-	41.25	2.74	-	-	-
Trading Asset Securities	30.65	27.48	22	25.52	15.93	36.89
Cash & Short-Term Investments	181	217.11	225.7	284.75	175.75	87.31
Cash Growth	15.59%	-3.80%	-20.74%	62.02%	101.31%	-3.26%
Accounts Receivable	262.2	286.25	248.26	219.99	239.46	208.2
Other Receivables	18.94	15.57	3.04	3.73	0.38	2.64
Receivables	281.14	301.82	251.3	223.72	239.84	210.84
Inventory	158.39	159.68	145.8	116.32	136.68	87.08
Other Current Assets	74.36	7.39	12.02	6.93	6.72	2.61
Total Current Assets	694.89	686.01	634.83	631.72	558.99	387.84
Property, Plant & Equipment	163.64	160.91	145.28	151.41	154.78	117.28
Long-Term Investments	80.64	57.95	72.66	32.1	0.45	0.45
Goodwill	7.01	7.01	7.01	-	-	-
Other Intangible Assets	18.21	21.18	25.06	25.87	31.69	36.92
Long-Term Accounts Receivable	-	28.51	5.73	3.75	6.42	13.61
Long-Term Deferred Tax Assets	8.85	8.51	6.35	6.35	4.46	3.05
Long-Term Deferred Charges	-	0.08	0.04	0.08	0.08	0.03
Other Long-Term Assets	34.54	45.95	2.23	23.8	22.38	22.67
Total Assets	1,008	1,016	899.18	875.07	779.25	581.85
Accounts Payable	125.81	172.11	142.32	124.39	162.79	101.85
Accrued Expenses	-	-	-	-	40.2	25.85
Short-Term Debt	-	-	-	-	0.22	15.49
Current Portion of Long-Term Debt	0.41	0.41	0.56	1.13	15.27	18.78
Current Portion of Leases	11.95	11.47	12.28	11.96	8.56	9.9
Current Income Taxes Payable	5.19	1.4	2.22	40.39	7.22	6.23
Current Unearned Revenue	-	-	-	-	33.4	4.35
Other Current Liabilities	148.77	93.15	68.45	62.23	11.58	6.91
Total Current Liabilities	292.13	278.54	225.83	240.11	279.22	189.35
Long-Term Debt	-	0.31	0.73	1.29	2.42	18.38
Long-Term Leases	41.83	36.07	37.99	44.36	40.28	34.35
Long-Term Unearned Revenue	14.5	60.33	4.11	-	6.08	5.53
Long-Term Deferred Tax Liabilities	2.78	2.94	3.15	6.72	7.58	9.87
Other Long-Term Liabilities	12.91	12.77	14.28	7.02	0.12	0.9
Total Liabilities	365.94	392.61	286.08	299.49	335.71	258.38
Common Stock	12.48	12.48	12.48	12.48	12.48	11.23
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5	19.83
Retained Earnings	562.03	544.92	515.41	472.39	334.63	214.11
Treasury Stock	-9.2	-9.2	-3.49	-	-	-
Comprehensive Income & Other	-73.97	-75.19	-61.79	-59.79	-54.07	-22.38
Total Common Equity	641.83	623.51	613.1	575.57	443.54	222.79
Minority Interest	-	-	-	-	-	100.68
Shareholders' Equity	641.83	623.51	613.1	575.57	443.54	323.48
Total Liabilities & Equity	1,008	1,016	899.18	875.07	779.25	581.85
Total Debt	54.19	48.27	51.55	58.74	66.74	96.9
Net Cash (Debt)	126.81	168.84	174.15	226.02	109.01	-9.59
Net Cash Growth	16.82%	-3.04%	-22.95%	107.33%	-	-
Net Cash Per Share	11.33	15.09	15.44	20.04	10.22	-0.96
Filing Date Shares Outstanding	11.17	11.28	11.28	11.28	11.28	10.04
Total Common Shares Outstanding	11.17	11.19	11.25	11.28	11.28	10.04
Working Capital	402.76	407.47	409	391.61	279.77	198.49
Book Value Per Share	57.46	55.73	54.52	51.02	39.32	22.20
Tangible Book Value	616.61	595.32	581.04	549.7	411.85	185.87
Tangible Book Value Per Share	55.20	53.21	51.67	48.73	36.51	18.52
Land	-	0.06	0.06	0.06	0.06	0.07
Machinery	-	244.49	212.94	193.36	188.2	151.27
Leasehold Improvements	-	25.19	24.04	25.51	25.36	15.67

Source: S&P Capital IQ. Standard template. Financial Sources.